Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

News feed

VTB's SPO price is set at ₽67 per share

9/19/25 VTBR

Shareholders of Headhunter approved dividends

9/19/25 HEAD

AFK Sistema may sell its stake in Element Group of Companies

9/19/25 ELMT

Cian plc has received permission to redomicile

9/18/25 CNRU

AFK Sistema and Roscosmos to create satellite constellation

9/18/25 AFKS

Ozon strengthens logistics with new warehouse

9/18/25 OZON

Whoosh audience in 6 months of 2025 has grown by 24%

9/18/25 WUSH

Rostelecom has introduced a payment terminal based on the Aurora OS

9/17/25 RTKM

Cherkizovo started production of sausages over a meter long

9/17/25 GCHE

TMK plans in 2025 to export 300 thousand tons of pipes

9/17/25 TRMK